Compare LEG & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEG | PLSE |
|---|---|---|
| Founded | 1883 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2018 | 2015 |
| Metric | LEG | PLSE |
|---|---|---|
| Price | $9.33 | $25.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.50 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 2.8M | 328.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | ★ 145.31 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $5,203,900,000.00 | N/A |
| Revenue This Year | N/A | $840.00 |
| Revenue Next Year | $2.73 | $287.54 |
| P/E Ratio | $66.39 | ★ N/A |
| Revenue Growth | ★ 1.37 | N/A |
| 52 Week Low | $7.86 | $12.56 |
| 52 Week High | $13.00 | $27.98 |
| Indicator | LEG | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 35.68 | 59.41 |
| Support Level | $9.28 | $17.58 |
| Resistance Level | $10.15 | $26.30 |
| Average True Range (ATR) | 0.37 | 1.75 |
| MACD | -0.16 | 0.56 |
| Stochastic Oscillator | 8.74 | 69.75 |
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.